Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Controlled Release"
DOI: 10.1016/j.jconrel.2017.10.006
Abstract: &NA; Anti‐angiogenic and vascular disrupting therapies rely on the dependence of tumors on new blood vessels to sustain tumor growth. We previously reported a potent vascular disrupting agent, a theranostic nanosystem consisting of a tumor… read more here.
Keywords: changes tumors; resistant vascular; treatment; vascular disrupting ... See more keywords
Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.18_suppl.lba6008
Abstract: LBA6008Background: Patients with gestational trophoblastic tumors (GTT) resistant to monochemotherapy are treated with historic chemotherapy regimens known to be effective, but toxic. PD-L1 is cons... read more here.
Keywords: avelumab patients; patients gestational; trophoblastic tumors; tumors resistant ... See more keywords